Monday, November 7, 2016

BRIEF-Adalta enters into commercialisation agreement with crossbeta biosciences

* Will receive royalties on future revenues from

commercialization of aßo-specific shark antibodies as novel

therapeutics or diagnostic agents

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)